Previous 10 | Next 10 |
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors Mont-Saint-Guibert, Belgium – January 9, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on...
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program Mont-Saint-Guibert, Belgium – December 22, 2022, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (...
Nyxoah to Participate in the Piper Sandler 34 th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 17 , 202 2 , 10 : 3 0 p m CET / 4 : 3 0 p m E...
Nyxoah S.A. (NYXH) Q3 2022 Results Earnings Conference Call November 08, 2022, 04:30 PM ET Company Participants Jeremy Feffer - Vice President, Investor Relations Olivier Taelman - Chief Executive Officer Loïc Moreau - Chief Financial Officer Conferenc...
Nyxoah press release ( NASDAQ: NYXH ): Q3 GAAP EPS of -€0.24. Revenue of €182M (-10.3% Y/Y). For further details see: Nyxoah GAAP EPS of -€0.24, revenue of €182M
REGULATED INFORMATION Nyxoah Reports Third Quarter 202 2 Financial and Operating Results DREAM US pivotal 12-month clinical data expected in fall of 2023 Mont-Saint-Guibert, Belgium – November 8 , 2...
Nyxoah A nnounces C hange to Board of Directors Mont-Saint-Guibert, Belgium – October 24 , 202 2 , 10 : 3 0 p m CET / 4 : 3 0 p m ET – Nyxoah SA ( Euronext...
Nyxoah to Participate in the Jefferies London Healthcare Conference Mont-Saint-Guibert, Belgium – October 20 , 202 2 , 10 : 3 0 p m CET / 4 : 3 0 p m ET – ...
Nyxoah to Release Third Quarter Financial Results on November 8 , 2022 Mont-Saint-Guibert, Belgium – October 18 , 202 2 , 10 : 3 0 p m CET / 4 : 3 0 p m ET ...
Nyxoah to Participate in the 17 th Annual Wells Fargo Securities Healthcare Conference Mont-Saint-Guibert, Belgium – August 18, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Companyȁ...
News, Short Squeeze, Breakout and More Instantly...
Nyxoah Appoints Scott Holstine as Chief Commercial Officer Mont-Saint-Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the ...
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (&...
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024 , 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the develop...